FutureChem Co.,Ltd (KOSDAQ:220100)

South Korea flag South Korea · Delayed Price · Currency is KRW
19,100
-600 (-3.05%)
Apr 28, 2026, 3:30 PM KST
0.10%
Market Cap 441.72B
Revenue (ttm) 18.67B
Net Income (ttm) -11.25B
Shares Out 22.42M
EPS (ttm) -508.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 90,154
Average Volume 79,589
Open 19,440
Previous Close 19,700
Day's Range 18,900 - 19,590
52-Week Range 14,900 - 35,050
Beta 0.78
RSI 46.67
Earnings Date May 13, 2026

About FutureChem Co.,Ltd

FutureChem Co.,Ltd engages in the research and development, production, and sale of chemicals, pharmaceuticals, and medical devices in South Korea and internationally. The company offers radioactive pharmaceuticals, including [18F]FDG for the treatment of general cancer diagnosis, PDvue for Parkinson's disease, Alzavue for Alzheimer's disease, and FLT for the lung cancer diagnosis. Its products in pipeline include [18F]FC303, [177Lu]FC705, and 225Ac for the treatment of prostate cancer; F-FMT for brain tumor diagnosis; FC-505 for the treatment ... [Read more]

Sector Healthcare
Founded 1999
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 220100
Full Company Profile

Financial Performance

In 2025, FutureChem Co.,Ltd's revenue was 18.67 billion, an increase of 7.96% compared to the previous year's 17.29 billion. Losses were -11.25 billion, 19.5% more than in 2024.

Financial Statements

News

There is no news available yet.